{{Rsnum
|rsid=6131
|Gene=SELP
|Chromosome=1
|position=169611647
|Orientation=minus
|GMAF=0.214
|Gene_s=SELP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 35.4 | 60.2
| HCB | 5.1 | 27.0 | 67.9
| JPT | 3.5 | 25.7 | 70.8
| YRI | 8.2 | 50.3 | 41.5
| ASW | 8.8 | 49.1 | 42.1
| CHB | 5.1 | 27.0 | 67.9
| CHD | 7.3 | 34.9 | 57.8
| GIH | 8.9 | 39.6 | 51.5
| LWK | 7.3 | 35.5 | 57.3
| MEX | 0.0 | 25.9 | 74.1
| MKK | 1.3 | 31.4 | 67.3
| TSI | 2.9 | 31.4 | 65.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24504449
|Title=SELP genetic polymorphisms may contribute to the pathogenesis of coronary heart disease and myocardial infarction: a meta-analysis
}}

{{PMID Auto
|PMID=15726497
|Title=Gene-environment interaction effects on the development of immune responses in the 1st year of life.
|OA=1
}}

{{PMID Auto
|PMID=16820586
|Title=Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery.
|OA=1
}}

{{PMID Auto
|PMID=18187665
|Title=Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.
|OA=1
}}

{{PMID Auto
|PMID=19131662
|Title=A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
|OA=1
}}

{{PMID Auto
|PMID=19263529
|Title=Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
|OA=1
}}

{{PMID Auto
|PMID=19330901
|Title=Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study.
|OA=1
}}

{{PMID Auto
|PMID=19404301
|Title=Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE.
|OA=1
}}

{{PMID Auto
|PMID=19559392
|Title=A candidate gene association study of 77 polymorphisms in migraine.
|OA=1
}}

{{PMID Auto
|PMID=20401335
|Title=Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}